![Terrie Curran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Terrie Curran
Directeur/Bestuurslid bij
ARCUTIS BIOTHERAPEUTICS, INC.
Vermogen: 4 M $ op 31-05-2026
Profiel
Ms. Terrie Curran is an Independent Director at Arcutis Biotherapeutics, Inc. She is on the Board of Directors at Arcutis Biotherapeutics, Inc. and Roivant Sciences, Inc. Ms. Curran was previously employed as a President, Chief Executive Officer & Director by Phathom Pharmaceuticals, Inc., an Independent Director by Myovant Sciences Ltd., an Independent Director by H.
Lundbeck A/S, a President-Global Inflammation & Immunology by Celgene Corp., a SVP & GM-Global Women's Health by Merck & Co., Inc., and a General Manager by Schering-Plough Corp.
She also served on the board at BioNJ, Inc. She received her undergraduate degree from the University of Technology Sydney.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 23-03-2026 | 389.860 ( 0,49% ) | 4 M $ | 31-05-2026 | |
| 05-06-2026 | 17.748 ( 0,01% ) | 380 872 $ | 31-05-2026 |
Actieve functies van Terrie Curran
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Directeur/Bestuurslid | 02-11-2020 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Directeur/Bestuurslid | - |
Eerdere bekende functies van Terrie Curran
| Bedrijven | Functie | Einde |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Algemeen Directeur | 31-03-2025 |
| MYOVANT SCIENCES LTD. | Directeur/Bestuurslid | 10-03-2023 |
| CELGENE | Corporate Officer/Principal | 01-09-2019 |
| H. LUNDBECK A/S | Directeur/Bestuurslid | 01-03-2017 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-04-2013 |
Opleiding van Terrie Curran
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
62
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
University of Technology Sydney
 University of Technology Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Phathom Pharmaceuticals, Inc.
 Phathom Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel treatments for gastrointestinal diseases and disorders | Health Technology |
